New research available on Bioniche Life Sciences

Posted by Laura Swartz

February 28, 2011 at 9:48 AM

This morning, we published a new Quarterly Update on Bioniche Life Sciences Inc. (BNC-TSX; BNC-ASX). Bioniche is a Canadian company providing innovative research, technologies, and therapeutics for human and animal health worldwide. Bioniche is structured in three global business units: (1) Bioniche Therapeutics (Human Health); (2) Bioniche Animal Health; and (3) Bioniche Food Safety. The following key areas, among many other of Bioniche’s business initiatives, are profiled in this newest update, which is available free of charge on our website.

Read More

Topics: New Research

Recent Financial Results and Updates

Posted by Laura Swartz

February 14, 2011 at 9:50 AM

Last week, several companies within our coverage universe released financial results and corporate updates, including CEL-SCI Corporation (CVM-NYSE Amex), Pro-Pharmaceuticals Inc. (PRWP-OTC), and Advaxis Inc. (ADXS-OTC). In addition, Neuralstem, Inc. (CUR?-NYSE Amex)? announced a breakthrough in its clinical trials that it believes could greatly influence the treatment of amyotrophic lateral sclerosis (ALS) or Lou Gehrig’s disease—a potentially fatal neuromuscular disorder.

Read More

Topics: Newsworthy Events, Advaxis, CEL-SCI, Multikine

Large Pharma Increasing Investment in Emerging Countries

Posted by Laura Swartz

February 10, 2011 at 9:54 AM

Yesterday morning, Sanofi-Aventis SA (SNY-NYSE) released its 2010 financial results. Among other news, the company reported that emerging markets represented €9 billion in sales for the group, accounting for 29.9% of total sales and now representing the largest contributor to sales, by region. Sanofi-Aventis has previously reported an annual growth rate of 22.8% from 2005 to 2009 in emerging markets. In 2010, the company established Hangzhou Sanofi Minsheng Consumer Healthcare Co. in order to better access the consumer healthcare market in China. Currently, Sanofi-Aventis has three manufacturing facilities in Beijing, Hangzhou, and Shenzhen (Source: MedAdNews “Cardio Marketers Look East,” January 2011).

Read More

Topics: Newsworthy Events

Unilife to report 2Q FY 2011 financial results in the U.S. on Feb. 14

Posted by Laura Swartz

February 7, 2011 at 9:56 AM

After market close today, Crystal Research published a business update on Unilife Corp. (UNIS-NASDAQ). Beyond covering Unilife’s recent significant news and progress under its Industrialization Agreement with sanofi-aventis SA (SNY-NYSE), the update also includes an early look at Unilife’s financials for the second quarter of FY 2011, ended December 31, 2010. This data comes from Unilife’s Appendix 4C for the three and six months ended December 31, 2010, filed on January 31, 2011, with the Australian Securities Exchange (ASX).

Read More

Topics: Crystal Research Associates, New Research

Content not found
Receive Our Research Notifications

About This Blog

We provide investor-based research and corporate communications services to companies worldwide. Visit our About Us page to learn more.

Posts by Date

see all

Posts by Topic